Clinical and prognostic implications of atrial fibrillation in patients undergoing transcatheter aortic valve implantation

Table 1 Baseline characteristics of the transcatheter aortic valve implantation population in atrial fibrillation and non-atrial fibrillation groups (n = 17) n (%)

	AF group	SR group	P
Male gender	6 (35.3)	7 (41.2)	0.72
Age (yr)	81.3	83.9	0.15
Diabetes	8 (47.1)	6 (35.3)	0.49
Hypertension	14 (82.4)	9 (52.9)	0.07
Peripheral vascular disease	4 (23.5)	1 (5.9)	0.15
Significant coronary disease	6 (35.3)	10 (58.8)	0.17
Prior stroke	3 (17.7)	2 (11.8)	0.63
Chronic respiratory failure	2 (11.8)	4 (23.5)	0.37
Chronic renal failure	3 (17.7)	0	0.07
Hemodialysis	2 (11.8)	0	0.14
Prior warfarin use	15 (88.2)	0	< 0.01
Logistic euroSCORE (mean)	27.9	18.7	0.07
Baseline echocardiogram features
Aortic valve area (cm2, mean)	0.66	0.72	0.35
Peak gradient (mmHg, mean)	76.9	71.4	0.42
Mean gradient (mmHg, mean)	44.2	41.8	0.60
LVEF (mean)	55.9%	57.5%	0.66

AF: Atrial fibrillation; SR: Sinus rhythm; LVEF: Left ventricular ejection fraction.